Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients

PHASE3CompletedINTERVENTIONAL
Enrollment

515

Participants

Timeline

Start Date

April 30, 2011

Primary Completion Date

October 31, 2013

Study Completion Date

October 31, 2013

Conditions
Pulmonary Fibrosis
Interventions
DRUG

placebo

placebo matching BIBF1120, BID

DRUG

BIBF 1120

BIBF1120 BID (twice daily)

Trial Locations (98)

Unknown

1199.32.10007 Boehringer Ingelheim Investigational Site, Birmingham

1199.32.10029 Boehringer Ingelheim Investigational Site, Jasper

1199.32.10013 Boehringer Ingelheim Investigational Site, Phoenix

1199.32.10005 Boehringer Ingelheim Investigational Site, Los Angeles

1199.32.10022 Boehringer Ingelheim Investigational Site, Danbury

1199.32.10025 Boehringer Ingelheim Investigational Site, Newark

1199.32.10023 Boehringer Ingelheim Investigational Site, Weston

1199.32.10001 Boehringer Ingelheim Investigational Site, Council Bluffs

1199.32.10028 Boehringer Ingelheim Investigational Site, Wichita

1199.32.10016 Boehringer Ingelheim Investigational Site, Minneapolis

1199.32.10024 Boehringer Ingelheim Investigational Site, New Brunswich

1199.32.10019 Boehringer Ingelheim Investigational Site, New York

1199.32.10004 Boehringer Ingelheim Investigational Site, Cincinnati

1199.32.10020 Boehringer Ingelheim Investigational Site, Portland

1199.32.10002 Boehringer Ingelheim Investigational Site, Pittsburgh

1199.32.10033 Boehringer Ingelheim Investigational Site, Pittsburgh

1199.32.10008 Boehringer Ingelheim Investigational Site, Providence

1199.32.10015 Boehringer Ingelheim Investigational Site, Nashville

1199.32.10034 Boehringer Ingelheim Investigational Site, Shelbyville

1199.32.10009 Boehringer Ingelheim Investigational Site, Dallas

1199.32.10018 Boehringer Ingelheim Investigational Site, McKinney

1199.32.10021 Boehringer Ingelheim Investigational Site, Falls Church

1199.32.10003 Boehringer Ingelheim Investigational Site, Lynchburg

1199.32.10038 Boehringer Ingelheim Investigational Site, Tacoma

1199.32.61001 Boehringer Ingelheim Investigational Site, Camperdown

1199.32.61002 Boehringer Ingelheim Investigational Site, Concord

1199.32.61003 Boehringer Ingelheim Investigational Site, Daw Park

1199.32.61005 Boehringer Ingelheim Investigational Site, Frankston

1199.32.61004 Boehringer Ingelheim Investigational Site, Prahran

1199.32.32004 Boehringer Ingelheim Investigational Site, Brussels

1199.32.32005 Boehringer Ingelheim Investigational Site, Jette

1199.32.32001 Boehringer Ingelheim Investigational Site, Leuven

1199.32.32002 Boehringer Ingelheim Investigational Site, Yvoir

1199.32.86001 Boehringer Ingelheim Investigational Site, Beijing

1199.32.86002 Boehringer Ingelheim Investigational Site, Beijing

1199.32.86005 Boehringer Ingelheim Investigational Site, Changsha

1199.32.86004 Boehringer Ingelheim Investigational Site, Chengdu

1199.32.86003 Boehringer Ingelheim Investigational Site, Nanchang

1199.32.86006 Boehringer Ingelheim Investigational Site, Xi'an

1199.32.42002 Boehringer Ingelheim Investigational Site, Prague

1199.32.42003 Boehringer Ingelheim Investigational Site, Prague

1199.32.42001 Boehringer Ingelheim Investigational Site, Ústí nad Labem

1199.32.33002 Boehringer Ingelheim Investigational Site, Bobigny

1199.32.33003 Boehringer Ingelheim Investigational Site, Nice

1199.32.33001 Boehringer Ingelheim Investigational Site, Paris

1199.32.33005 Boehringer Ingelheim Investigational Site, Paris

1199.32.33006 Boehringer Ingelheim Investigational Site, Paris

1199.32.33007 Boehringer Ingelheim Investigational Site, Reims

1199.32.33004 Boehringer Ingelheim Investigational Site, Rennes

1199.32.49008 Boehringer Ingelheim Investigational Site, Bamberg

1199.32.49005 Boehringer Ingelheim Investigational Site, Donaustauf

1199.32.49001 Boehringer Ingelheim Investigational Site, Essen

1199.32.49002 Boehringer Ingelheim Investigational Site, Freiburg/Breisgau

1199.32.49006 Boehringer Ingelheim Investigational Site, Giessen

1199.32.49003 Boehringer Ingelheim Investigational Site, Großhansdorf

1199.32.49007 Boehringer Ingelheim Investigational Site, Heidelberg

1199.32.49004 Boehringer Ingelheim Investigational Site, Mainz

1199.32.91003 Boehringer Ingelheim Investigational Site, Ahmedabad

1199.32.91002 Boehringer Ingelheim Investigational Site, Coimbatore

1199.32.91006 Boehringer Ingelheim Investigational Site, Jaipur

1199.32.91005 Boehringer Ingelheim Investigational Site, Kolkata

1199.32.91001 Boehringer Ingelheim Investigational Site, Mumbai

1199.32.35301 Boehringer Ingelheim Investigational Site, Dublin

1199.32.97004 Boehringer Ingelheim Investigational Site, Haifa

1199.32.97001 Boehringer Ingelheim Investigational Site, Petah Tikva

1199.32.97002 Boehringer Ingelheim Investigational Site, Rehovot

1199.32.39012 Boehringer Ingelheim Investigational Site, Catania

1199.32.39004 Boehringer Ingelheim Investigational Site, Chieti Scalo

1199.32.39008 Boehringer Ingelheim Investigational Site, Forlì

1199.32.39005 Boehringer Ingelheim Investigational Site, Milan

1199.32.39001 Boehringer Ingelheim Investigational Site, Modena

1199.32.39007 Boehringer Ingelheim Investigational Site, Monza

1199.32.39011 Boehringer Ingelheim Investigational Site, Napoli

1199.32.39002 Boehringer Ingelheim Investigational Site, Padua

1199.32.39006A Boehringer Ingelheim Investigational Site, Pisa

1199.32.39006B Boehringer Ingelheim Investigational Site, Pisa

1199.32.39010 Boehringer Ingelheim Investigational Site, Roma

1199.32.39009 Boehringer Ingelheim Investigational Site, Siena

1199.32.81005 Boehringer Ingelheim Investigational Site, Bunkyo-ku,Tokyo

1199.32.81006 Boehringer Ingelheim Investigational Site, Bunkyo-ku,Tokyo

1199.32.81007 Boehringer Ingelheim Investigational Site, Kiyose, Tokyo

1199.32.81004 Boehringer Ingelheim Investigational Site, Kumagaya, Saitama

1199.32.81009 Boehringer Ingelheim Investigational Site, Minato-ku, Tokyo

1199.32.81003 Boehringer Ingelheim Investigational Site, Naka-gun, Ibaraki

1199.32.81011 Boehringer Ingelheim Investigational Site, Ota-ku, Tokyo

1199.32.81001 Boehringer Ingelheim Investigational Site, Sendai, Miyagi

1199.32.81010 Boehringer Ingelheim Investigational Site, Shibuya-ku, Tokyo

1199.32.81002 Boehringer Ingelheim Investigational Site, Shimotsuke,Tochigi

1199.32.81008 Boehringer Ingelheim Investigational Site, Shinjuku-ku, Tokyo

1199.32.81012 Boehringer Ingelheim Investigational Site, Yokohama, Kanagawa

1199.32.44006 Boehringer Ingelheim Investigational Site, Aberdeen

1199.32.44003 Boehringer Ingelheim Investigational Site, Birmingham

1199.32.44005 Boehringer Ingelheim Investigational Site, Birmingham

1199.32.44009 Boehringer Ingelheim Investigational Site, Leeds

1199.32.44004 Boehringer Ingelheim Investigational Site, Liverpool

1199.32.44002 Boehringer Ingelheim Investigational Site, London

1199.32.44008 Boehringer Ingelheim Investigational Site, Oxford

1199.32.44001 Boehringer Ingelheim Investigational Site, Westbury on Trym

Sponsors
All Listed Sponsors
lead

Boehringer Ingelheim

INDUSTRY

NCT01335464 - Safety and Efficacy of BIBF 1120 at High Dose in Idiopathic Pulmonary Fibrosis Patients | Biotech Hunter | Biotech Hunter